Asher Bio is a company focused on developing cis-targeted immunotherapies that engage two receptors on the same immune cell to provide a new level of selectivity in immune cell activation.

Asher Bio

Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco. 

Y Combinator

Evan Cheng

Third Rock Ventures

Invus

Boxer Capital

MBC BioLabs

Wellington Management

Alexandria Venture Investments

Logos Capital

Marshall Wace

Mission BioCapital

Janus Henderson Investors

RA Capital Management

Asher Biotherapeutics

COM:ASHERBIO

Asher Bio

Filings Not Available